Azosemide
Azosemide is a loop diuretic used to manage fluid retention (oedema) associated with congestive heart failure and certain kidney or liver conditions. It works by inhibiting sodium and chloride reabsorption in the kidneys, increasing urine production and helping the body eliminate excess fluid and salt. Azosemide is commonly available as oral tablets, with dosage determined by the patient’s condition and response to treatment. Possible side effects include increased urination, dizziness, dehydration, low blood pressure, and electrolyte imbalances. Medical supervision is important, with monitoring of kidney function, electrolyte levels, and blood pressure; rare but serious reactions can include reduced white blood cell counts.
Azosemide was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Azosemide, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Azosemide from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Azosemide, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
